Indacaterol Maleate
Cat.No:II1740 Solarbio
CAS:753498-25-8
Molecular Formula:C28H32N2O7
Molecular Weight:508.56
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > Endocrinology & Hormones > Indacaterol MaleateCAS:753498-25-8
Molecular Formula:C28H32N2O7
Molecular Weight:508.56
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
| CAS | 753498-25-8 |
| Name | Indacaterol Maleate |
| Molecular Formula | C28H32N2O7 |
| Molecular Weight | 508.56 |
| Solubility | Soluble in DMSO ≥10mg/mL |
| Purity | ≥98% |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
| MDL | MFCD20526769 |
| SMILES | CCC1=C(C=C2CC(CC2=C1)NCC(C3=C4C=CC(=O)NC4=C(C=C3)O)O)CC.C(=CC(=O)O)C(=O)O |
| InChIKey | IREJFXIHXRZFER-PCBAQXHCSA-N |
| InChI | InChI=1S/C24H28N2O3.C4H4O4/c1-3-14-9-16-11-18(12-17(16)10-15(14)4-2)25-13-22(28)19-5-7-21(27)24-20(19)6-8-23(29)26-24;5-3(6)1-2-4(7)8/h5-10,18,22,25,27-28H,3-4,11-13H2,1-2H3,(H,26,29);1-2H,(H,5,6)(H,7,8)/b;2-1-/t22-;/m0./s1 |
| PubChem CID | 9827599 |
| Target Point | Adrenergic Receptor |
| Passage | Endocrinology & Hormones;GPCR & G Protein;Neuronal Signaling |
| Background | It is a long-acting beta-adrenergic receptor agonist. |
| Biological Activity | Indacaterol Maleate 是一种长效的β-肾上腺素受体激动剂,对β1-adrenoceptor的pKi为 7.36,对 β2-adrenoceptor 的pKi为5.48,可以用于治疗哮喘和慢性阻塞性肺病。[1] |
| Data Literature Source | [1]. Battram C,et al. In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol),a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of action. J Pharmacol Exp Ther. 2006 May;317(2):762-70. [2]. Sturton RG,et al. Pharmacological characterization of indacaterol,a novel once daily inhaled 2 adrenoceptor agonist,on small airways in human and rat precision-cut lung slices. J Pharmacol Exp Ther. 2008 Jan;324(1):270-5. [3]. Naline E,et al. Effect of indacaterol,a novel long-acting beta2-agonist,on isolated human bronchi. Eur Respir J. 2007 Mar;29(3):575-81. [4]. Scola AM,et al. The long-acting beta-adrenoceptor agonist,indacaterol,inhibits IgE-dependent responses of human lung mast cells. Br J Pharmacol. 2009 Sep;158(1):267-76. [5]. Sayers I,et al. Pharmacogenetic characterization of indacaterol,a novel beta 2-adrenoceptor agonist. Br J Pharmacol. 2009 Sep;158(1):277-86. |
| Unit | Bottle |
| Specification | 25mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download